Biological effects of recombinant vaccinia virus-expressed interleukin 4

This publication has 15 references indexed in Scilit:

• Interferon gamma is involved in the recovery of athymic nude mice from recombinant vaccinia virus/interleukin 2 infection.
  The Journal of Experimental Medicine, 1990
• Immunodeficient mice recover from infection with vaccinia virus expressing interferon‐γ
  European Journal of Immunology, 1989
• Recombinant interleukin 4 suppresses the production of interferon gamma by human mononuclear cells.
  The Journal of Experimental Medicine, 1989
• Vaccinia-Interleukin 2 Recombinant Virus or Exogenous Interleukin 2 Does Not Alter the Magnitude or Immune Response Gene Defects of the Cytotoxic T-Cell Response to Vaccinia Virus in Vivo
  Scandinavian Journal of Immunology, 1989
• Regulation of IgG1 and IgE Production by Interleukin 4
  Immunological Reviews, 1988
• Prevention of vaccinia virus infection in imiminodeficient mice by vector-directed IL-2 expression
  Nature, 1987
• Regulation of cytolytic T-lymphocyte generation by B-cell stimulatory factor
  Nature, 1987
• B cell stimulatory factor 1 (interleukin 4) is a potent costimulant for normal resting T lymphocytes.
  The Journal of Experimental Medicine, 1987
• B cell-stimulatory factor 1 (BSF-1) promotes growth of helper T cell lines.
  The Journal of Experimental Medicine, 1986
• Temporal regulation of influenza hemagglutinin expression in vaccinia virus recombinants and effects on the immune response
  European Journal of Immunology, 1986